Evaluation of Cardioprotective Activity of Tamarindus indica Linn Pericarpic extract in Doxorubicin induced Cardiotoxicity in Experimental Rats

 

VKK Mandlem*, N. Gouri Priya, M. Raghavendra, K. Abbulu

CMR College of Pharmacy, Kandlakoya (V), Medchal Road, Hyderabad-501401.

*Corresponding Author E-mail: arunakiran4u@gmail.com

 

ABSTRACT:

Background: Cardiovascular diseases are major death causing issue globally. Dietary polyphenols can maintain or enhance cardiovascular health conditions. Every part of tamarind has numerous pharmacological properties. However, so far pericarp (shell) of tamarind fruit which contain polyphenols is not evaluated for cardioprotective activity. Hence the present study was designed to evaluate cardioprotective role of Tamarindus indica Linn pericarpic extract against doxorubicin (DOX) induced cardiotoxicity. Materials and Methods: The hydroalcoholic extract of Tamarind pericarp (HAETP) was prepared by cold maceration and subjected to preliminary phytochemical investigation. Albino wistar rats were randomized into 5 groups (n=6), group I received normal saline as vehicle daily, group II received vehicle + single dose of DOX (20mg/kg body weight i.p) on 29th day, groups III IV and V were pretreated with amlodipine (5mg/kg body weight p.o), HAETI (200 and 400 mg/kg body weight p.o) respectively followed by DOX on 29th day. On 31st day change in body weight, heart weight and serum parameters (LDH, CK-MB, AST, ALT and Calcium) were evaluated. Animals were sacrificed and heart tissue was used to estimate oxidative stress biomarkers (LPO, GSH and CAT), membrane bounded enzymes (Na+/k+ ATPase, Ca++ ATPase and Mg++ ATPase) and histopathological studies. Results: DOX treated rats significantly increased the levels of serum cardiac and oxidative stress biomarkers which were reversed by HAETP treated rats. The alterations caused by DOX in Na+/k+ ATPase, Ca++ ATPase and Mg++ ATPase levels were restored in HAETP treated rats and protected myocardium from toxic effect of DOX. Conclusion: The results reveal that tamarind pericarp has cardioprotective activity which might be due to its antioxidant properties.

 

KEYWORDS: Tamarindus indica Linn, doxorubicin, cardiotoxicity, cardioprotective, membrane bounded enzymes.

 

 


INTRODUCTION:

At present cardiovascular diseases (CVD’s) are being the major health burden with superlative mortality rate globally. The one fourth of all mortality is accountable to myocardial disorders1. Myocardial Ischemia and Cardiopulmonary arrest been the prevalent causes, these are also extremely responsible for more than 85% of CVD deaths.

 

As indicated by the Global Burden of the Disease Study age-institutionalized evaluations (2011), almost a quarter (24.8 per cent) of all passing in India are owing to cardiovascular diseases2.

 

Several Chronic diseases including CVD are result of Oxidative stress that develops due to increased origination of free radicals and ROS in the body3. Trend growing in researches for evaluation of medicinal plants for CVD by using cardio toxic models for example, doxorubicin induced cardiotoxicity to investigate cardioprotective properties of many medicinal plants.

 

Cardiotoxicity (C.T) is referred as any toxic effect on heart muscles, although the exact definition of it is still lacking4. C.T caused by chemotherapeutic agents can be toxic in nature cause myocardial damage and known to have high prevalence5. It develops irregular heart rhythms as the heart becomes incapable for pumping required blood to distribute essential O2 and nutrients to the whole body. C.T leads to cardiopulmonary arrest, myocardial ischemia/ infraction, QT prolongation, left ventricular failure, pericarditis, thromboembolism and exaggerated blood pressures6.

 

Doxorubicin (DOX) an anthracycline drug and potent broad spectrum chemotherapy agent, useful in several kinds of cancer like leukemia, strong tumors, breast cancer, small cell lung carcinoma and esophageal carcinoma. Many studies demonstrated administration of DOX above supra maximal dose causes cardiac dysfunctions due to generation of excessive reactive oxygen species (ROS)7. The most important cellular damage caused by ROS includes lipid peroxidase, crosslinking of protein, DNA damage8,9. These leads to cardiomyopathy damaged mitochondrial biogenesis, decreased Na+/k+ ATPase activity, overloading of calcium10.

 

Plant based antioxidants which can protect the cells from oxidative damage should be incorporated in the potential antioxidant therapy. Therefore there is a need for discovery of alternative, natural, safer sources of antioxidants.

 

Tamarindus indica linn is a part of the Fabaceae family, commonly referred to as tamarind widely used as traditional food and in ayurvedic herbal therapies. Several studies reported T. indica is a multipurpose tree, every part of which finds at least some use either nutritional or medicinal. The pericarp of tamarind fruit contains phenolic antioxidants11. Its polyphenolic profile is dominated by proanthocyanidins. These proanthocyanidins are a type of oligomeric flavanoids also referred as condensed tannins mostly found in peels of fruits and vegetables are utilized as powerful antioxidants12.

 

Thus, keeping in view the above mentioned facts, the current study was designed to evaluate the cardioprotective activity of Tamarindus indica pericarpic extract against doxorubicin induced cardiaotoxicity in albino rats.

 

MATERIALS AND METHODS:

Drugs and chemicals:

Doxorubicin Hydrochloride injection (Doxoruba IP-50mg/25ml; Company: Getwell Oncology Pvt. Ltd) was purchased from local hospital pharmacy. Kits for serum analysis were procured from coral diagnostics (LDH, CK-MB, AST, ALT and Calcium).

 

Collection and Authentication of plant material:

The pericarps (shells) of Tamarindus indica fruits were collected from local market of Hyderabad, Telangana, India. The plant material was authenticated by Dr. P. V. Prasanna Scientist F at Botanical Survey of India, Deccan Regional Centre Hyderabad. Voucher specimens were stored in the department of Pharmacology, CMR College of Pharmacy, Hyderabad, Telangana state, India.

 

Preparation of the extract:

The pericarps (shells) of tamarind fruits were peeled, washed with distilled water and dried under sunshade, and then they were powdered using a mechanical grinder. Then the powdered material was mixed with concentration of 80:20 respectively (Water: Ethanol) and kept at 25oC for one week with occasional shaking13. Thereafter, it was stirred for 20min and filtered. The filtrate was dried in rotary evaporator (ROTA VAP). The hydroalcoholic extract of Tamarind pericarp (HAETP) was subjected to preliminary phytochemical investigation14 and stored in refrigerator at 4oC for further studies.

 

Animals:

Adult male albino rats of Wistar strain weighing 170-200g were obtained from Sainath Agencies, #1-6-197/45/D, Balaji Nagar, Musheerabad, Hyderabad-500048, (282/PO/Bt/S/2000/CPCSEA). Acclimatization of animals to the laboratory environment was done for a week. The animals were randomly housed in polypropylene cages along with paddy husk as bedding, in a well ventilated room under hygienic conditions and were exposure to 12 hour day and night cycle. The animals were fed with commercial rat pellet feed and were given water ad libitum. All the experimental methodology and conventions utilized in this investigation were approved by the Institutional Animal Ethics Committee (IAEC) of CMR College of pharmacy, Hyderabad, (1657/PO/Re/S/12/CPCSEA).

 

Groups:

The adult male rats of wistar strain has been divided into 5 groups of 6 animals each and exposed to following treatments for 30 days.

 

Group I: Normal control group: received normal saline 5 ml/kg body weight p.o as vehicle for 30 days.

 

Group II: Disease control group: Treated with single dose of DOX-20mg/kg body weight i.p on 29th day.

 

Group III: Standard control group: Received Amlodipine 5 mg/kg body weight p.o for 30 days and DOX-20mg/kg body weight i.p on 29th day.

 

Group IV: HAETP 200mg: Received HAETP 200mg mg/kg body weight p.o for 30 days and DOX-20mg/kg body weight i.p on 29th day.

 

Group IV: HAETP 400mg: Received HAETP 400mg mg/kg body weight p.o for 30 days and DOX-20mg/kg body weight i.p on 29th day.

 

After 31st day, blood samples were collected from the retro orbital plexus for the estimation of serum analysis. Later, animals were sacrificed under anesthesia and hearts were isolated for in vivo antioxidant studies, membrane bound enzyme assays and histopathological studies.

 

Acute toxicity study:

Acute toxicity study was performed according to the guidelines of OECD 425. Two groups of male Wistar rats (n=3 in each group) were used for the study. First group received HAETP-2000 mg/kg p.o, second group received vehicle, distilled water. After administration, animals were observed individually at least once every 30min, periodically during the first 24 h, with special attention given during the first 4 hours and daily. Thereafter, observed continuously for a total of 14 days for the profiles such as lethargy, alertness, irritability, spontaneous activity, changes in skin, fur and eyes, behavior pattern, tremors, convulsions, salivation, defecation and urination, coma and death. HAETP was well tolerated and showed no morbidity and mortality. Based on the results, the 1/10th and 1/5th of the maximum tolerated dose were selected i.e. 200 mg/kg and 400mg/kg respectively by oral route for further studies.

 

Dose selection and experimental induction of myocardial toxicity or cardiac stress:

Dose of Doxorubicin as 20mg/kg body weight i.p was selected based on previous studies15. Commercially available doxorubicin was used for experimental induction of myocardial toxicity or cardiac stress.

 

Estimation of biochemical parameters:

Serum markers:

At the end of the study, blood samples were collected from the retro orbital plexus. Blood samples were kept aside for approximately 1hr at room temperature and centrifuged at 2500rpm at 4oC for 15min to separate the serum from blood. The serum samples were used for estimation of various biochemical parameters such as Lactate dehydrogenase (LDH), Aspartate transaminase (AST), Alanine transaminase (ALT), Creatine kinase (CK-MB) and Calcium by using coral kits and semi auto analyzer (Inkarp ES-100).

 

Biomarkers of the oxidative stress:

After blood collection, animals were sacrificed by cervical dislocation and were cut open to isolate heart and were weighed immediately. The isolated heart was chopped into slices and was chilled in the ice cold potassium chloride (1.15%). These fine slices were homogenized in ice cold potassium chloride (1.15%) using tissue homogenizer. It was then centrifuged at 5000rpm at 4oC for 20min to separate the homogenate from cellular debris. The supernatant was collected and used to estimate oxidative stress markers such as Malondialdehyde level as indicator of Lipid peroxidation (LPO)16, Reduced glutathione (GSH)17 and Catalase (CAT)18.

 

Membrane bound enzymes:

The above prepared tissue homogenates were also used for estimation of membrane bounded enzymes such as Na+/k+ ATPase19, Ca++ ATPase20 and Mg++ ATPase21 activities.

 

Histopathological studies:

The parts of the hearts after euthanasia were stored in 10% (w/v) buffered formalin and embedded in paraffin, sections were cut at four µm thick, stained with Hematoxylin and Eosin (H and E) reagents. These sections were observed under light microscope for histopathological changes.

 

Statistical analysis:

The values were expressed as Mean ±SEM. The Statistical analysis was carried out by one-way Analysis of variance followed by post hoc Dunnett’s test using graph pad prism 5.0. The values are significant at p<0.05.

 

RESULTS:

Preliminary phytochemical screening:

Preliminary phyto chemical studies of hydro alcoholic extract of Tamarindus indica. pericarp specified in the Table.1

 

Table 1: List of phytochemical constituents present in HAETP

Name of the phytoconstituent

HAETP

Alkaloids

Present

Saponins

Present

Carbohydrates

Present

Flavonoids

Present

Glycosides

Present

Proteins

Absent

Steroids

Present

Tannins and phenolic compounds

Present

Amino acids

Present

 

Effect of HAETP treatment individually on body weights on 1st and 31st Day:

Body weight in disease control group showed significant decrease compared to normal, whereas in standard and HAETP treatment groups there was a significant increase in the body weight as shown in Table.2.

 

Effect of HAETP treatment on heart weight on 31st Day:

The disease control group showed significant increase in heart weight with comparison to normal and standard group. The treatment groups standard amlodipine, HAETP 200mg/kg and HAETP 400mg/kg showed significant decrease in heart weight compared to the disease control group as shown in the Table.3.

 


Table 2: Effect of HAETP treatment individually on body weights on 1st and 31st Day

Groups

Normal control

Disease Control (Doxorubicin 20 mg/kg)

Standard Amlodipine(5mg/kg)

HAETP

(200mg/kg)

HAETP

(400mg/kg)

Change of body weights (grams)

1st day

182±3.07

177±3.33

182±3.07

178±4.01

183±5.58

31stday

203±4.22

183±2.11

217±3.33

192±1.67

215±9.57

 

 


Table 3: Effect of HAETP treatment on heart weight on 31st Day

S. No

Name of the group

Heart weights (gm)

1

Normal

0.458±0.00543

2

Disease control (Doxorubicin 20 mg/kg)

0.567±0.0154

3

Standard Amlodipine (5mg/kg)

0.477±0.00715

4

HAETP 200 mg

0.520±0.00447

5

HAETP 400 mg

0.503±0.00667

 

Effect of HAETP treatment on serum cardiac markers against doxorubicin induced toxicity:

The disease control group showed significant increase (p<0.001) in the levels of LDH, AST, ALT, CK-MB and calcium levels with comparison to the normal and the standard group. The treatment groups, standard amlodipine, HAETP 200mg/kg and HAETP 400mg/kg showed decrease (p<0.001) in the levels LDH, AST, ALT, CK-MB and calcium levels with comparison to the disease control group. The estimated values were presented as Mean ± SEM in Table.4.

 


Table 4: Effect of HAETP treatment on serum cardiac cardioprotective parameters

S. No

Name of the group

LDH

(IU/L)

AST

(mg/ml)

ALT

(mg/ml)

CK-MB

(IU/L)

CALCIUM

(mg/dl)

1

Normal

340±5.61

42.3±1.98

34.3±1.09

334±11.4

5.88±0.169

2

Disease control (Doxorubicin 20mg/kg)

553±18.3d

97.6±1.65d

77.5±2.03d

637±19.5d

18.1±0.163d

3

Standard Amlodipine (5 mg/kg)

356±11.6a

44.8±0.909a

35.1±1.13a

337±12.0a

4.92±0.233a

4

HAETP200mg

473±2.79ad

62.9±3.58ad

47.0±1.45ae

503±26.4ad

8.24±0.713ad

5

HAETP400mg

420±18.0ae

51.6±1.53a

42.7±0.295af

451±6.08ad

6.13±0.281a

Values are represented as Mean ± SEM. Statistical analysis performed using one way ANOVA followed by post hoc Dunnett’s test. ap<0.001, bp<0.01 and cp<0.05 Vs Disease control; dp<0.001, ep<0.01 and fp<0.05 Vs Standard Amlodipine.

 


Effect of HAETP treatment on oxidative stress markers against doxorubicin induced cardiotoxicity:

Effect of HAETP on oxidative stress markers such as lipid peroxidation, reduced glutathione and catalase of cardiac tissue homogenate was summarized in Table.5. There was significant increase in the lipid peroxidation level and decrease in the levels of reduced glutathione and catalase observed in disease control (p< 0.001) when compared to the normal and standard groups. Significant improvement was observed in the levels of lipid peroxidation, catalase and reduced glutathione (p< 0.001) in standard Amlodipine group when compared to the disease control group. Treatment with HAETP showed significant recovery from lipid peroxidation and increased levels of reduced glutathione and catalase in a dose dependent manner (p< 0.001 and p< 0.01) when compared to the disease control.

 

Table 5: Effect of HAETP treatment on oxidative stress markers

S. No

Name of the group

LPO

(µM/mg)

GSH

(µM/mg)

CAT

(µM/mg)

1

Normal

3.44±0.073

8.62±0.425

0.593±0.04

2

Disease control (Doxorubicin 20 mg/kg)

11.1±0.301d

2.23±0.26d

0.074±0.01d

3

Standard Amlodipine (5 mg/kg)

4.11±0.23a

8.61±0.26a

0.632±0.02a

4

HAETP 200 mg

6.61±0.14ad

6.05±0.49b

0.484±0.02ae

5

HAETP 400 mg

4.80±0.27a

8.40±1.53a

0.544±0.02a

Values are represented as Mean ± SEM. Statistical analysis performed using one way ANOVA followed by post hoc Dunnett’s test. ap<0.001, bp<0.01 and cp<0.05 Vs Disease control; dp<0.001, ep<0.01 and fp<0.05 Vs Standard Amlodipine.

 


Effect of HAETP treatment on membrane bounded enzymes of heart against doxorubicin induced cardiotoxicity:

Effect of HAETP on membrane bound enzymes such as Na+/K+-ATPase and Mg++-ATPase and Ca++-ATPase of cardiac tissue homogenate was summarized in Table.6. There was significant decrease in the Na+/K+-ATPase and Mg++-ATPase levels and increase in the levels of Ca ++-ATPase observed in disease control (p< 0.001) when compared to the normal and standard groups. Standard Amlodipine group showed significant increase (p< 0.001) in the Na+/K+-ATPase and Mg++-ATPase levels and decrease (p< 0.001) in the levels of Ca++-ATPase levels when compared to the disease control group. Treatment with HAETP showed significant recovery from Ca++-ATPase and increased levels of Na+/K+-ATPase and Mg++-ATPase in a dose dependent manner (p< 0.001), (p< 0.01) and (p< 0.05) when compared to the disease control group.

 

Table 6: Effect of HAETP treatment on membrane bounded enzymes

S. No

Name of the group

Na+/k+ ATPase

(µM/mg)

Ca++ ATPase

(µM/mg)

Mg++ ATPase

(µM/mg)

1

Normal

1.85±0.04

0.688 ± 0.06

0.0638 ± 0.002

2

Disease control (Doxorubicin 20 mg/kg)

1.24±0.04d

1.60 ± 0.05d

0.0312 ± 0.002d

3

Standard Amlodipine  (5 mg/kg)

1.83±0.03a

0.698 ± 0.06a

0.0608 ± 0.003a

4

HAETP 200 mg

1.65±0.10a

1.32 ± 0.016bd

0.0458 ± 0.007

5

HAETP 400 mg

1.69±0.10a

0.783 ± 0.07a

0.0497 ± 0.007c

Values are represented as Mean ± SEM. Statistical analysis performed using one way ANOVA followed by post hoc Dunnett’s test. ap<0.001, bp<0.01 and cp<0.05 Vs Disease control; dp<0.001, ep<0.01 and fp<0.05 Vs Standard Amlodipine.

 


Histopathological studies:

Histopathological examination of treatment groups are shown in the Fig.1 (a-e). Normal control rat showed normal integrity of myocardial fibres with no vacuoles, necrosis, inflammation and infarction. The heart section of disease control rats showed largely covered irregular shaped hypertrophic fibres with loss of striations, intracytoplasmic vacuoles present in fibres, leukocyte infiltration and inflammation of myocardium. Standard Amlodipine (5mg/kg) treated rats showed normal shaped sized myocardial fibres with no vacuolation. HAETP 200mg/kg and 400mg/kg pretreated rats showed mild to moderate protection against doxorubicin toxicity evidenced by reduction in the loss of striations, necrotic region, infiltration of Leukocytes, and increase in restoration of normal integrity of myocardial fibres.

 

           

Fig. No. 1 (a-e). Effect of HAETP treatment on histopathological studies against doxorubicin induced cardiotoxicity.

 

DISCUSSION:

The present study was done to investigate cardioprotective role of HAETP against DOX induced cardiotoxicity. Our experimental data suggests that HAETP prevents DOX induced cardiotoxicity in rats. Following lines are emphasized as evidences of the present study. The preliminary phyto-chemical evaluation was performed with HAETP and it revealed that it contains flavanoids, phenols, tannins, alkaloids, glycosides as major components22. In DOX treated or disease control group, development of color change of animal fur to pink has been seen in post observational days was follow on with red exudates at eyes and nose. These were less seen in the HAETP pretreated animals, revealing its protective property.

 

The DOX treated group showed increase in heart weight indicating loss in myofibrils, dilating sarcoplasmic reticulum, and enlargement of mitochondria. These changes were opposed in the HAETP pretreated groups. The HAETP pretreated rats shown significant increase in body weights contrast to DOX treated group this might be due to fewer intakes of water and food. Increase in body weight in the HAETP pretreated rats indicate that they have ability to alter the oxidative stress occurring from doxorubicin treatment

 

The LDH level rises in myocardial infarction and it raises 4-5 times more to normal also up to 12 times the value of normal. CK-activity gets elevated in cellular damage contributing skeletal muscle, heart muscle, brain injury etc. Increase in levels of certain CK-isoenzyme in blood is of particular diagnostic value. The LDH and CK-MB values are important aspects of measurement of late and early cardiac injuries23.

 

Serum AST and ALT enzymes are very important for the smooth regulation in breaking down and making up processes in human bodies24. The current study reports that AST, ALT proportions were increased in the disease control group indicating inflammation and necrosis.

 

The increase in levels of LDH and CK-MB in DOX treated group reveals damage particularly occurred in cardiac tissues and indicates myocardial infarction. Pretreatment with HAETP-200mg/kg showed slight reduction and HAETP-400mg/kg showed significant decrease in the proportions of DOX -induced elevated LDH, AST, ALT and CK-MB indicating moderate protection of myocardial tissues towards doxorubicin toxicity.

 

Doxorubicin induced cardiotoxicity shows rise in intracellular calcium concentration in the heart tissues due to impairment of calcium handling which prompts alterations in contractions and relaxations of the heart25. It also suggests that it causes interferences in mitochondrial calcium regulation and irreversible decrease in loading capacity leading to loss in myocardial function26. This was opposed in HAETP pretreated (200mg/kg and 400mg/kg) groups contrast to DOX treated group.

 

The appropriate mechanism responsible for cardiotoxicity which is instigated by doxorubicin has not been clearly revealed from the present study but due to lot of evidences from earlier studies it shows doxorubicin suppresses characteristic antioxidants and raises oxygen free radicals prompting high levels oxidative stress promoting alterations in cardiac cells and typically cardiac injury27. In present study, DOX treated group showed significant rise in MDA concentration in heart muscles prompting high range of lipid peroxidation, also GSH and CAT levels were suppressed indicating myocardium damage.

 

HAETP pretreated rats showed dose dependent reduction in cardiac MDA concentration additionally rise in GSH and CAT contrast to disease control group which reveals that it has a protective role towards cardiac tissues.

 

Heart function gets affected by change in the activities of ion pumps namely, Na+/k+ ATPase, Ca++ ATPase and Mg++ ATPase. These membrane bound enzymes have important role in contraction and relaxation properties of cardiac muscles. In this study DOX treated group showed decreased levels of Na+/k+ ATPase, Mg++ ATPase and increase in Ca++ ATPase level evident that doxorubicin destroys cell membranes as reported in earlier studies28. HAETP pretreated (200mg/kg and 400mg/kg) groups restored the levels of Na+/k+ ATPase, Ca++ ATPase and Mg++ ATPase indicating membrane stabilizing properties which support the previous studies.

 

Histopathological changes of cardiotoxicity induced by DOX includes increasing order of severity, swelling of sarcoplasmic reticulum, vacuolization in cytoplasm, degeneration of myocardial fibres, disruption in myocytes and fibrosis29. In our study we observed no morphological changes in normal control rats and heart showed normal uniform size, shape and arrangement of myocardial fibres with no infiltration and necrosis. In heart sections of DOX treated group, hypertrophic fibres, vacuoles in the cytoplasm, alteration in the myocyte structure, damaged microtubules, infiltered inflammatory cells, degeneration of myocardial fibres were observed which were in line with previous reports. These findings were reversed in HAETP pretreated groups and standard amlodipine group. Less degeneration of myocardial fibres and only single vacuole was observed in the HAETP 200mg/kg. In HAETP 400mg/kg group and standard amlodipine group normal configuration of cardiac muscle fibres with normal shaped and sized myocytes were observed which is due to reversal of infiltration of inflammatory components and fragmentation of cardiac fibres. The protection exhibited by HAETP as observed from histopathological alterations may be due to its antioxidant potency to counteract the free radicals.

 

CONCLUSION:

The present study suggests that HAETP has moderate protective effects towards doxorubicin induced cardiotoxicity in rats. Pretreatment of HAETP (200mg/kg) and HAETP (400mg/kg) showed significant reduction in DOX-elevated serum marker enzymes- LDH, AST, ALT, CK-MB, and Calcium levels. HAETP treated groups showed significant decrease in heart MDA levels with increase in levels of GSH and CAT contrast to DOX treated group suggesting existence of antioxidant properties. Pretreated HAETP groups showed restoration of membrane bound enzymes such as Na+ /K+ ATPase, Ca++ ATPase, Mg++ ATPase indicating membrane stabilizing properties. The histopathological studies reveals morphological changes in heart caused by DOX induced cardiotoxicity were reversed by HAETP pretreated groups indicating protective effects against free radicals. However, futher studies should be performed to elucidate detailed cardioprotective mechanism.

 

ACKNOWLEDGEMENT:

We are thankful to the Principal, and Management CMR College of Pharmacy for providing infrastructure facilities for the present study.

 

CONFLICT OF INTEREST:

There are no conflicts of interest.

 

REFERENCES:

1.      Prabhakaran D, Jeemon P, Roy A. Cardiovascular diseases in India: current epidemiology and future directions. Circulation. 2016 Apr 19;133(16):1605-20.

2.      Mendis S, Puska P, Norrving B, World Health Organization. Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization; 2011.

3.      Zhang X, Zhu Y, Dong S, Zhang A, Lu Y, Li Y, Lv S, Zhang J. Role of oxidative stress in cardiotoxicity of antineoplastic drugs. Life Sciences. 2019 Jun 3.

4.      M. Scherrer-Crosbie. Anti-Cancer Treatments and Cardiotoxicity. Mechanisms, Diagnostic and Therapeutic Interventions 2017, Pages 35-38

5.      Grenier, M. A., and Lipshultz, S. E. (1998). Epidemiology of anthracycline cardiotoxicity in children and adults. Seminars in Oncology, 25(4 SUPPL. 10), 72-85

6.      Larussi D, Indolfi P, Casale F, et al. Recent Advances in the Prevention of Anthracycline Cardiotoxicity in Childhood. Cur Med Chem. 2001;13:1649-1660.

7.      Sterba M et al. Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection. Antioxidants and Redox Signaling. 2013;18(8):899-929

8.      Spallarossa P et al. A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity. Journal of Cardiovascular Medicine. 2016;17:e84-e92

9.      Varricchi G et al. Antineoplastic drug-induced cardiotoxicity: A redox perspective. Frontiers in Physiology. 2018;9:167.

10.   Koleini N, Nickel BE, Edel AL, Fandrich RR, Ravandi A, Kardami E. Oxidized phospholipids in Doxorubicin-induced cardiotoxicity. Chemico-Biological Interactions. 2019 Jan 29.

11.   Sudjaroen Y, Haubner R, Würtele G, Hull WE, Erben G, Spiegelhalder B, Changbumrung S, Bartsch H, Owen RW. Isolation and structure elucidation of phenolic antioxidants from Tamarind (Tamarindus indica L.) seeds and pericarp. Food and Chemical Toxicology. 2005 Nov 1;43(11):1673-82.

12.   Bhadoriya, Santosh Singh and Ganeshpurkar, Aditya and Narwaria, Jitendra and Rai, Gopal and Jain, Alok. (2011). Tamarindus indica: Extent of explored potential. Pharmacognosy Reviews. 5. 73-81. 10.4103/0973-7847.79102.

13.   Ghosh S, Chatterjee JK, Chalkroborty B, Hazra AK. Comparison of different aqueous extraction methods for optimum extraction of polyphenols and in-vitro anti-oxidant activity from pomegranate peel. Journal of Pharmacognosy and Phytochemistry. 2019; 8(3): 342-7.

14.   Ananth V. Pharmacognostical and preliminary phytochemical profile of the leaf extracts of Embelia ribes Burm. F. Journal of Pharmacognosy and Phytochemistry. 2019;8(1):1861-4.

15.   15.Khan G, Haque SE, Anwer T, Ahsan MN, Safhi MM, Alam MF. Cardioprotective effect of green tea extract on doxorubicin-induced cardiotoxicity in rats. Acta Pol Pharm. 2014 Sep 1;71(5):861-868.

16.   Lowry OH. Rosebrough, NJ, Farr, AL, and Randall, RJ Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951 Nov;193(1):265-75.

17.   Sedlak J., Lindsay R.H.: Anal. Biochem. 25,192 (1968).

18.   Claiborne A.: Catalase activity, in Handbook of Methods for Oxygen Radical Research. Greenwald R.A. Ed., pp. 283ń284, CRC Press, Boca Raton 1985/

19.   Fiske, C. H., And Subbarow, Y., J. Biol. Chem., 66, 375

20.   Hjerten S, Pan H. Purification and characterization of two forms of a low affinity Ca2+ATPase from erythrocyte membranes. Biochim Biophys Acta 1983;728:281-8.

21.   Ohnishi T, Suzuki T, Suzuki Y, Ozawa K. A comparative study of plasma membrane Mg2+ATPase activities in normal, regenerating and malignant cells. Biochim Biophys Acta 1982;684:67-74.

22.   Gomathi AC, Rajarathinam SX, Sadiq AM. Phyto chemical screening of aqueous extract of Tamarind (Tamarindus indica L.) Shell. International Journal of Basic and Applied Research. 2017;7(11).

23.   M. Santosh Kumar, Viswanatha Swamy Mallinathaiah Agadi Hiremath Cardioprotective effect of Acorus calamus against doxorubicin-induced myocardial toxicity in albino Wistar rats. Indian Journal of Health Sciences, May-Aug 2016, Vol 9, Issue 2.

24.   Bhupati, L.V.S., S. Muvvala, and P. Shashank. Protective effect of Vitis vinifera in doxorubicin induced oxidative stress in rats- A preliminary study. International Journal of Advances in Pharmacy Medicine and Bioallied Sciences 2:7-14 (2014)

25.   V. Madhava Reddy Papasani, B. Hanumantharayappa, A. Annapurna. Cardioprotective Effect of Naringin Against DoxorubicinInduced Cardiomyopathy in Rats. Indo American Journal of Pharm Research. 2014:4(05).

26.   Zhou S, Starkov A, Froberg MK, Leino RL, Wallace KB. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Research. 2001 Jan 1;61(2):771-7.

27.   J. M. Kulkarni, A. H. M. Viswanatha Swamy Cardioprotective effect of gallic acid against doxorubicin-induced myocardial toxicity in albino rats Indian Journal of Health Sciences, Jan-Jun 2015, Vol 8,Issue 1.

28.   Kumar MS, Hiremath VS. Cardioprotective effect of Acorus calamus against doxorubicin-induced myocardial toxicity in albino Wistar rats. Indian j health sci 2016; 9:225-34.

29.   Chalcroft SC, Gavin JB, Herdson PB. Fine structural changes in rat myocardium induced by daunorubicin. Pathology. 1973 Jan 1; 5(2):99-105.

 

 

 

 

Received on 04.09.2019           Modified on 10.11.2019

Accepted on 16.12.2019         © RJPT All right reserved

Research J. Pharm. and Tech. 2020; 13(7): 3267-3273.

DOI: 10.5958/0974-360X.2020.00579.X